Targeting Multidrug Resistance in Cancer by Natural Chemosensitizers

Bulletin of the National Research Centre
doi 10.1186/s42269-019-0043-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Trametinib Modulates Cancer Multidrug Resistance by Targeting ABCB1 Transporter

Oncotarget
Oncology
2015English

miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1

Cancer Management and Research
Oncology
2019English

Stable Reversal of Multidrug Resistance in Colon Cancer Cells by RNA Interference Targeting the MDR1 Gene

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2009English

Multidrug Resistance in Prostate Cancer

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2003English

MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1

Oncology Letters
Cancer ResearchOncology
2017English

Starvation, Detoxification, and Multidrug Resistance in Cancer Therapy

Drug Resistance Updates
Cancer ResearchOncologyInfectious DiseasesPharmacology
2012English

Multidrug Resistance Proteins (MRPs) and Cancer Therapy

AAPS Journal
Pharmaceutical Science
2015English

Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism

Cancer Research
Cancer ResearchOncology
2011English

Dietary Natural Flavonoids Treating Cancer by Targeting Aryl Hydrocarbon Receptor

Critical Reviews in Toxicology
Toxicology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy